John T. Henderson, Director at CYTOKINETICS INC (CYTK), sold 5,000 shares at $85.14 ($426K) on 2024-01-12, disclosed to the SEC on 2024-01-12.
Scheduled sale ($426k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTK | SELL | 2025-04-16 | $247K | — | Filing → |
| CYTK | SELL | 2024-12-12 | $179K | — | Filing → |
| CYTK | SELL | 2024-04-25 | $1.4M | — | Filing → |